FDA Panel Rejects Broad Pfizer Booster Jabs Scuttling Biden’s Plan, Endorses Limited Shots For “At Risk” Elderly

It's a legit revolt. The White House is not happy. Here's the strategy to roll out boosters, right from their COVID plan. pic.twitter.com/WTK7W5Vdjd

— Jordan Schachtel @ dossier.substack.com (@JordanSchachtel) September 17, 2021

• FDA Panel Rejects Broad Pfizer Booster Jabs Scuttling Biden’s Plan, Endorses Limited Shots For “At Risk” Elderly
  by Tyler Durden, https://www.zerohedge.com/
  Update (1620ET): Minutes after the FDA advisory panel rejected the Biden Administration’s plan to dole out booster shots to patients as young as 16, the same panel returned and voted unanimously to temporarily approve Pfizer Booster jabs for patients who are either a.) 65 or older, b.) immunocompromised or c.) both.
  –
  Ultimately, the panel voted 18-0 to support an emergency-use authorization (a more limited clearance than a full approval sought by the administration and Pfizer) for people 65 and older or individuals at high risk of severe COVID.
  –
  Ahead of the vote, analysts at several Wall Street banks and research shots told clients a limited authorization would be the most likely outcome amid a groundswell of opposition for a broad booster dose.
  –
  read more.

If you are young and relatively health, Covid is not dangerous for you…

Says the damn FDA… https://t.co/TG3XwycurM

— T (@SevenSeasGoonie) September 17, 2021

end